170 related articles for article (PubMed ID: 19076379)
21. Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis.
Bopp C; Bierhaus A; Hofer S; Bouchon A; Nawroth PP; Martin E; Weigand MA
Crit Care; 2008; 12(1):201. PubMed ID: 18226173
[TBL] [Abstract][Full Text] [Related]
22. The use of activated protein C (drotrecogin alfa (activated)) in the treatment of severe sepsis.
Murgo M; Adamson H; Boyle M
Aust Crit Care; 2003 Nov; 16(4):133-43. PubMed ID: 14692158
[TBL] [Abstract][Full Text] [Related]
23. A two-decade journey in identifying high mobility group box 1 (HMGB1) and procathepsin L (pCTS-L) as potential therapeutic targets for sepsis.
Li J; Zhu CS; He L; Qiang X; Chen W; Wang H
Expert Opin Ther Targets; 2023; 27(7):575-591. PubMed ID: 37477229
[TBL] [Abstract][Full Text] [Related]
24. Hmgb-1 as a therapeutic target for infectious and inflammatory disorders.
Mantell LL; Parrish WR; Ulloa L
Shock; 2006 Jan; 25(1):4-11. PubMed ID: 16369179
[TBL] [Abstract][Full Text] [Related]
25. JH-4 reduces HMGB1-mediated septic responses and improves survival rate in septic mice.
Lee W; Yuseok O; Yang S; Lee BS; Lee JH; Park EK; Baek MC; Song GY; Bae JS
J Cell Biochem; 2019 Apr; 120(4):6277-6289. PubMed ID: 30378167
[TBL] [Abstract][Full Text] [Related]
26. Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria.
Chorny A; Anderson P; Gonzalez-Rey E; Delgado M
J Immunol; 2008 Jun; 180(12):8369-77. PubMed ID: 18523304
[TBL] [Abstract][Full Text] [Related]
27. Role of C5a-C5aR interaction in sepsis.
Guo RF; Riedemann NC; Ward PA
Shock; 2004 Jan; 21(1):1-7. PubMed ID: 14676676
[TBL] [Abstract][Full Text] [Related]
28. Baicalein protects against polymicrobial sepsis-induced liver injury via inhibition of inflammation and apoptosis in mice.
Liu A; Wang W; Fang H; Yang Y; Jiang X; Liu S; Hu J; Hu Q; Dahmen U; Dirsch O
Eur J Pharmacol; 2015 Feb; 748():45-53. PubMed ID: 25533331
[TBL] [Abstract][Full Text] [Related]
29. Neutralizing Complement C5a Protects Mice with Pneumococcal Pulmonary Sepsis.
Müller-Redetzky H; Kellermann U; Wienhold SM; Gutbier B; Lienau J; Hellwig K; Reppe K; Letsiou E; Tschernig T; Scholz M; Ahnert P; Maasch C; Hoehlig K; Klussmann S; Vater A; Firsching TC; Hoppe J; Suttorp N; Witzenrath M
Anesthesiology; 2020 Apr; 132(4):795-807. PubMed ID: 32101978
[TBL] [Abstract][Full Text] [Related]
30. Migration inhibitory factor in the cerebral and systemic endothelium in sepsis and malaria.
Clark I; Awburn M
Crit Care Med; 2002 May; 30(5 Suppl):S263-7. PubMed ID: 12004246
[TBL] [Abstract][Full Text] [Related]
31. Methylthiouracil, a new treatment option for sepsis.
Kwak S; Ku SK; Kang H; Baek MC; Bae JS
Vascul Pharmacol; 2017 Jan; 88():1-10. PubMed ID: 26239884
[TBL] [Abstract][Full Text] [Related]
32. Targeting high mobility group box 1 as a late-acting mediator of inflammation.
Czura CJ; Tracey KJ
Crit Care Med; 2003 Jan; 31(1 Suppl):S46-50. PubMed ID: 12544976
[TBL] [Abstract][Full Text] [Related]
33. [Role of macrophage migration inhibitory factor in mice with sepsis and after effect of its intervention].
Zhang ZH; Chen XH; Lin PY; Jiang HL; Xiong XM; Zhu YC
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Aug; 21(8):481-4. PubMed ID: 19695172
[TBL] [Abstract][Full Text] [Related]
34. [Role of alarmins high mobility group protein B1 in sepsis].
Wei J; Zhang Y; Ma X; Tian L; Liang H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Aug; 28(8):761-4. PubMed ID: 27434574
[TBL] [Abstract][Full Text] [Related]
35. Sulforaphane Reduces HMGB1-Mediated Septic Responses and Improves Survival Rate in Septic Mice.
Lee IC; Kim DY; Bae JS
Am J Chin Med; 2017; 45(6):1253-1271. PubMed ID: 28830206
[TBL] [Abstract][Full Text] [Related]
36. A small molecule binding HMGB1 inhibits caspase-11-mediated lethality in sepsis.
Wang X; Li Z; Bai Y; Zhang R; Meng R; Chen F; Wang H; Billiar TR; Xiao X; Lu B; Tang Y
Cell Death Dis; 2021 Apr; 12(4):402. PubMed ID: 33854044
[TBL] [Abstract][Full Text] [Related]
37. Sepsis Care Pathway 2019.
Labib A
Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
[No Abstract] [Full Text] [Related]
38. Persicarin is anti-inflammatory mediator against HMGB1-induced inflammatory responses in HUVECs and in CLP-induced sepsis mice.
Kim TH; Ku SK; Bae JS
J Cell Physiol; 2013 Apr; 228(4):696-703. PubMed ID: 22911316
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic potential of HMGB1-targeting agents in sepsis.
Wang H; Zhu S; Zhou R; Li W; Sama AE
Expert Rev Mol Med; 2008 Nov; 10():e32. PubMed ID: 18980707
[TBL] [Abstract][Full Text] [Related]
40. Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis.
Guo RF; Huber-Lang M; Wang X; Sarma V; Padgaonkar VA; Craig RA; Riedemann NC; McClintock SD; Hlaing T; Shi MM; Ward PA
J Clin Invest; 2000 Nov; 106(10):1271-80. PubMed ID: 11086028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
